Discussion topic: |
Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines? |
There will be two main presentations as follows: |
The Immunological benefits of mRNA and potential applications Regulatory approaches: Issues and challenges, and questions to be asked by regulators Dr Martin Friede, WHO will chair the meeting. |
Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?
- Details